Optical imaging of Cerenkov light generation from positron-emitting radiotracers

被引:364
作者
Robertson, R. [1 ]
Germanos, M. S. [1 ]
Li, C. [2 ,3 ]
Mitchell, G. S. [2 ,3 ]
Cherry, S. R. [2 ,3 ]
Silva, M. D. [1 ]
机构
[1] Millennium Pharmaceut Inc, Dept Imaging Sci, Cambridge, MA 02139 USA
[2] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA
[3] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA
关键词
FDG-PET; RADIATION;
D O I
10.1088/0031-9155/54/16/N01
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Radiotracers labeled with high-energy positron emitters, such as those commonly used for positron emission tomography studies, emit visible light immediately following decay in a medium. This phenomenon, not previously described for these imaging tracers, is consistent with Cerenkov radiation and has several potential applications, especially for in vivo molecular imaging studies. Herein we detail a new molecular imaging tool, Cerenkov Luminescence Imaging, the experiments conducted that support our interpretation of the source of the signal, and proof-of-concept in vivo studies that set the foundation for future application of this new method.
引用
收藏
页码:N355 / N365
页数:11
相关论文
共 16 条
[1]  
CLARKE LP, 1992, J NUCL MED, V33, P161
[2]   Cerenkov radiation [J].
Collins, GB ;
Reiling, VG .
PHYSICAL REVIEW, 1938, 54 (07) :499-503
[3]   USE OF CERENKOV RADIATION IN MEASUREMENT OF BETA-EMITTING RADIONUCLIDES [J].
ELRICK, RH ;
PARKER, RP .
INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1968, 19 (03) :263-+
[4]   CERENKOV RADIATION AND ITS APPLICATIONS [J].
JELLEY, JV .
BRITISH JOURNAL OF APPLIED PHYSICS, 1955, 6 (07) :227-232
[5]   Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development [J].
Kelloff, G ;
Hoffman, JM ;
Johnson, B ;
Scher, HI ;
Siegel, BA ;
Cheng, EY ;
Cheson, BD ;
O'Shaughnessy, J ;
Guyton, KZ ;
Mankoff, DA ;
Shankar, L ;
Larson, SM ;
Sigman, CC ;
Schilsky, RL ;
Sullivan, DC .
CLINICAL CANCER RESEARCH, 2005, 11 (08) :2785-2808
[6]  
LANNUNCIATA MF, 2003, HDB RADIOACTIVITY AN
[7]   FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma [J].
Mikhaeel, NG ;
Hutchings, M ;
Fields, PA ;
O'Doherty, MJ ;
Timothy, AR .
ANNALS OF ONCOLOGY, 2005, 16 (09) :1514-1523
[8]  
Mobley J., 2003, Biomedical Photonics Handbook, P36
[9]   Optical contrast agents and imaging systems for detection and diagnosis of cancer [J].
Pierce, Mark C. ;
Javier, David J. ;
Richards-Kortum, Rebecca .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (09) :1979-1990
[10]   MEASUREMENT OF BETA-EMITTING NUCLIDES USING CERENKOV RADIATION [J].
ROSS, HH .
ANALYTICAL CHEMISTRY, 1969, 41 (10) :1260-&